SELIN ABRAAMYAN: Open Payments
NPI 1144795899 · GLENDALE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,518 in 58 payments from 17 companies in 2025. Trend: 2023 $1,708 · 2024 $1,616 · 2025 $1,518
Food & beverage: $1,518
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 12 | $273 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 9 | $197 |
| ABIOMED | 6 | $184 |
| Merck Sharp & Dohme LLC | 5 | $144 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 4 | $115 |
| Edwards Lifesciences Corporation | 2 | $93 |
| AstraZeneca Pharmaceuticals LP | 3 | $73 |
| Amgen Inc. | 3 | $72 |
| PFIZER INC. | 3 | $70 |
| HEARTFLOW, INC. | 3 | $66 |
Products named: LEQVIO, JARDIANCE, VERQUVO, LifeVest, SAPIEN 3 Ultra RESILIA, Repatha, ELIQUIS, FFRct.
Industry payments across CA — which companies pay providers there.
